GLIOLA Trademark
Trademark Overview
On Friday, April 12, 2024, a trademark application was filed for GLIOLA with the United States Patent and Trademark Office. The USPTO has given the GLIOLA trademark a serial number of 98496546. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Tuesday, March 11, 2025. This trademark is owned by Best Well Stem Cell, Inc.. The GLIOLA trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical products for the treatment of infectious diseases; nutritive substances for micro-organisms for medical use; cellular function activating agents for medical purposes; dietetic substances being dietetic foods adapted for medical use; pharmaceuticals preparations for reagents to identify disease progression when administered during surgery; dermatological pharmaceutical products; Stem cells for medical use and purposes; Gene therapy products, namely, genetically engineered tissues for transplant purposes; surgical implants comprised of living tissues grown from stem cells
General Information
| Serial Number | 98496546 |
| Word Mark | GLIOLA |
| Filing Date | Friday, April 12, 2024 |
| Status | 681 - PUBLICATION/ISSUE REVIEW COMPLETE |
| Status Date | Tuesday, March 11, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, April 1, 2025 |
Trademark Statements
| Goods and Services | Pharmaceutical products for the treatment of infectious diseases; nutritive substances for micro-organisms for medical use; cellular function activating agents for medical purposes; dietetic substances being dietetic foods adapted for medical use; pharmaceuticals preparations for reagents to identify disease progression when administered during surgery; dermatological pharmaceutical products; Stem cells for medical use and purposes; Gene therapy products, namely, genetically engineered tissues for transplant purposes; surgical implants comprised of living tissues grown from stem cells |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, April 12, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | NOT AVAILABLE |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 01 - Individual |
| Address | Seoul 06004
KR |
| Party Name | NOT AVAILABLE |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 01 - Individual |
| Address | Seoul 06004
KR |
| Party Name | NOT AVAILABLE |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 01 - Individual |
| Address | Seoul 06004
KR |
| Party Name | NOT AVAILABLE |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 01 - Individual |
| Address | Seoul 06004
KR |
| Party Name | Best Well Stem Cell, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Seoul 06017
KR |
Trademark Events
| Event Date | Event Description |
| Friday, April 12, 2024 | NEW APPLICATION ENTERED |
| Monday, September 23, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, November 1, 2024 | NON-FINAL ACTION E-MAILED |
| Wednesday, January 29, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, October 25, 2024 | ASSIGNED TO EXAMINER |
| Friday, November 1, 2024 | NON-FINAL ACTION WRITTEN |
| Friday, November 1, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, January 28, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, January 28, 2025 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, March 6, 2025 | APPROVED FOR PUB - PRINCIPAL REGISTER |
